Search research articles
Contact Us
Filters
Showing results (101-110 of 161) with videos related to
Page
of 17
Sort By:
Pharmacoepidemiology and Drug Safety
|
June 8, 2012
Exploring large weight deletion and the ability to balance confounders when using inverse probability of treatment weighting in the presence of rare treatment decisions
Ryan D Kilpatrick, Dave Gilbertson, M Alan Brookhart, et al.
The Pediatric Infectious Disease Journal
|
July 1, 1996
Poliomyelitis in Ethiopia: virologic links to poliomyelitis cases in the Indian subcontinent
J P Alexander, W Alemu, D Kilpatrick, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
February 24, 2004
Role of specific CD8+ T cells in the severity of a fulminant zoonotic viral hemorrhagic fever, hantavirus pulmonary syndrome
Elizabeth D Kilpatrick, Masanori Terajima, Frederick T Koster, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
May 2, 2013
Trends in hip fracture rates in US hemodialysis patients, 1993-2010
Thomas J Arneson, Shuling Li, Jiannong Liu, et al.
Expert Opinion on Drug Safety
|
July 15, 2020
Impact of adverse event reports from marketing authorization holder-sponsored patient support programs on the performance of signal detection in pharmacovigilance
Inyoung Lee, Todd A Lee, Stephanie Y Crawford, et al.
British Heart Journal
|
June 1, 1980
Assessment of long-term plasma exchange for familial hypercholesterolaemia
G R Thompson, N B Myant, D Kilpatrick, et al.
Seminars in Oncology
|
August 1, 1997
Induction paclitaxel and carboplatin followed by concurrent chemoradiotherapy in patients with unresectable, locally advanced non-small cell lung carcinoma: report of Fox Chase Cancer Center study 94-001
C J Langer, B Movsas, R Hudes, et al.
Therapeutic Innovation & Regulatory Science
|
July 29, 2020
Exploring Completeness of Adverse Event Reports as a Tool for Signal Detection in Pharmacovigilance
Inyoung Lee, Jeremy D Jokinen, Stephanie Y Crawford, et al.
RMD Open
|
November 2, 2019
Incidence of inpatient venous thromboembolism in treated patients with rheumatoid arthritis and the association with switching biologic or targeted synthetic disease-modifying antirheumatic drugs (DMARDs) in the real-world setting
Huifang Liang, Raghava Danwada, Dianlin Guo, et al.
Journal of the American Society of Nephrology : JASN
|
June 8, 2013
Temporal trends in fracture rates and postdischarge outcomes among hemodialysis patients
Anne C Beaubrun, Ryan D Kilpatrick, Janet K Freburger, et al.
Page
of 17
Search research articles
Search
Showing results (101-110 of 161) with videos related to
Sort By:
Page
of 17
Pharmacoepidemiology and Drug Safety
|
June 8, 2012
Exploring large weight deletion and the ability to balance confounders when using inverse probability of treatment weighting in the presence of rare treatment decisions
Ryan D Kilpatrick, Dave Gilbertson, M Alan Brookhart, et al.
The Pediatric Infectious Disease Journal
|
July 1, 1996
Poliomyelitis in Ethiopia: virologic links to poliomyelitis cases in the Indian subcontinent
J P Alexander, W Alemu, D Kilpatrick, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
February 24, 2004
Role of specific CD8+ T cells in the severity of a fulminant zoonotic viral hemorrhagic fever, hantavirus pulmonary syndrome
Elizabeth D Kilpatrick, Masanori Terajima, Frederick T Koster, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
May 2, 2013
Trends in hip fracture rates in US hemodialysis patients, 1993-2010
Thomas J Arneson, Shuling Li, Jiannong Liu, et al.
Expert Opinion on Drug Safety
|
July 15, 2020
Impact of adverse event reports from marketing authorization holder-sponsored patient support programs on the performance of signal detection in pharmacovigilance
Inyoung Lee, Todd A Lee, Stephanie Y Crawford, et al.
British Heart Journal
|
June 1, 1980
Assessment of long-term plasma exchange for familial hypercholesterolaemia
G R Thompson, N B Myant, D Kilpatrick, et al.
Seminars in Oncology
|
August 1, 1997
Induction paclitaxel and carboplatin followed by concurrent chemoradiotherapy in patients with unresectable, locally advanced non-small cell lung carcinoma: report of Fox Chase Cancer Center study 94-001
C J Langer, B Movsas, R Hudes, et al.
Therapeutic Innovation & Regulatory Science
|
July 29, 2020
Exploring Completeness of Adverse Event Reports as a Tool for Signal Detection in Pharmacovigilance
Inyoung Lee, Jeremy D Jokinen, Stephanie Y Crawford, et al.
RMD Open
|
November 2, 2019
Incidence of inpatient venous thromboembolism in treated patients with rheumatoid arthritis and the association with switching biologic or targeted synthetic disease-modifying antirheumatic drugs (DMARDs) in the real-world setting
Huifang Liang, Raghava Danwada, Dianlin Guo, et al.
Journal of the American Society of Nephrology : JASN
|
June 8, 2013
Temporal trends in fracture rates and postdischarge outcomes among hemodialysis patients
Anne C Beaubrun, Ryan D Kilpatrick, Janet K Freburger, et al.
Page
of 17